UK markets open in 2 hours 59 minutes

Acurx Pharmaceuticals, Inc. (ACXP)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
4.4000-0.0350 (-0.79%)
At close: 04:00PM EST
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2020
31/12/2019
Total revenue
0
0
0
Operating expenses
Research development
1,771
2,203
3,510
Selling general and administrative
9,509
2,397
2,421
Total operating expenses
11,280
4,600
5,931
Operating income or loss
-11,280
-4,600
-5,931
Income before tax
-11,214
-4,600
-5,931
Income from continuing operations
-11,214
-4,600
-5,931
Net income
-11,214
-4,600
-5,931
Net income available to common shareholders
-11,214
-4,600
-5,931
Basic EPS
-
-0.74
-1.24
Diluted EPS
-
-0.74
-1.24
Basic average shares
-
8,891
7,502
Diluted average shares
-
8,891
7,502
EBITDA
-
-4,600
-5,931